top of page
Oxybutynin

奧昔布寧
Mechanism of action:
Oxybutynin 是一種毒蕈鹼型乙醯膽鹼受體抑制劑(muscarinic acetylcholine receptor inhibitor),主要拮抗 M₃ 受體,M₁、M₂ 為次要。正常情況下,M₃ 受體若被活化,會藉由 Gq 蛋白使 IP₃/Ca²⁺ 上升,促進膀胱收縮。Oxybutynin 抑制 M₃ 受體後,能讓逼尿肌放鬆。
Reference(s):
1. Douchamps J et al. (1988). The pharmacokinetics of oxybutynin in man. Eur J Clin Pharmacol.
2. Kennelly MJ et al. (2010). A comparative review of oxybutynin chloride formulations: pharmacokinetics and therapeutic efficacy in overactive bladder. Rev Urol.
3. Yarker YE et al. (1995). Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging.
bottom of page
